Literature DB >> 4928964

Amantadine in Parkinsonism. An extended prospective trial.

N S Rao, J Pearce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4928964

Source DB:  PubMed          Journal:  Practitioner        ISSN: 0032-6518


× No keyword cloud information.
  9 in total

1.  The comparative value of amantadine and levodopa.

Authors:  V Dallos; K Heathfield; P Stone; F Allen
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

2.  An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.

Authors:  N Calaghan; M McIlroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

3.  Mechanism of action of amantadine.

Authors:  J Pearce
Journal:  Br Med J       Date:  1971-08-26

4.  On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Experientia       Date:  1972-01-15

5.  Drug treatment in Parkinson's disease.

Authors:  J M Pearce
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

6.  Parkinsonism: If surgery is necessary, can it help spontaneous movement and motor fatiguing?

Authors:  C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

Review 7.  Current concepts of Parkinsonism.

Authors:  J Pearce; I Pearce
Journal:  Postgrad Med J       Date:  1971-12       Impact factor: 2.401

Review 8.  Adverse effects of antiparkinsonian drugs.

Authors:  J D Parkes
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

Review 9.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.